Digital Twins in Healthcare Market Summary
The digital twins in healthcare market size was valued at USD 2,094.73 million in 2024, and it is projected to reach USD 15,211.73 million by 2032. The market is expected to grow at a CAGR of 28.17% during the forecast period from 2025 to 2032. This growth is mainly driven by the rising prevalence of chronic diseases, expanding applications in drug discovery and clinical trials, and continued advancements in AI, IoT, and big data analytics. North America is projected to hold the largest share of the market in 2024, while Asia-Pacific is expected to be the fastest-growing region.
Explore DelveInsight’s Full Coverage on the Digital Twins in Healthcare Market
Digital Twins in Healthcare Market Overview
A digital twin in healthcare is a virtual, computational replica of a patient, device, or hospital system that enables real-time simulation of health conditions, treatment planning, and outcome prediction. The market is segmented by type into Patient Digital Twins, Device Digital Twins, and Hospital Digital Twins; by technology into Artificial Intelligence (AI), Machine Learning (ML), and Internet of Things (IoT); and by application into Chronic Disease Management, Patient Monitoring, Surgical Simulation, Predictive Analysis, and Others. Among these, the patient digital twin category is estimated to account for the largest market share in 2024, driven by the growing prevalence of chronic diseases and the expanding range of clinical applications and benefits associated with the technology.
Digital Twins in Healthcare Market Dynamics
The market is being propelled by a sharp rise in chronic disease incidence across major disease areas:
- According to GLOBOCAN (2024), approximately 20 million new cancer cases were reported globally in 2022, projected to rise to 32.6 million by 2045; in the WHO Eastern Mediterranean Region alone, cancer diagnoses are expected to double from over 788,000 in 2022 to around 1.57 million by 2045
- The British Heart Foundation (2024) reported approximately 640 million people affected by heart and circulatory diseases worldwide, with around 67 million new diagnoses each year, while the Annals of Thoracic Surgery (2024) estimated over 1 million cardiac surgical procedures performed globally each year
- The International Diabetes Federation (2023) reported 537 million adults aged 20–79 living with diabetes in 2021, projected to rise to 643 million by 2030 and 783 million by 2045
- The World Health Organization (2023) reported over 300 million surgeries performed annually worldwide, with the National Institutes of Health recording more than 15.8 million surgical procedures globally in 2023
These trends, combined with technological innovation such as Dassault Systèmes’ September 2023 launch of “Emma Twin,” a digital avatar showcasing the power of virtual twins in healthcare, continue to drive market expansion. However, high development and implementation costs, along with data privacy and security concerns, remain key constraints limiting market growth.
Digital Twins in Healthcare Market Players
Key companies operating in the digital twins in healthcare market research landscape include:
- Siemens Healthineers AG
- IBM
- Koninklijke Philips N.V.
- Oracle
- Virtonomy GmbH
- Microsoft
- Unity Technologies
- Verto Health
- Dassault Systèmes
- ANSYS, Inc.
- Twins Digital Services India Private Limited
- SAP
- NVIDIA Corporation
- Exactcure
- TCS
- Unlearn.ai, Inc.
- PrediSurge
- Q Bio
- Cisco Systems, Inc.
- GE HealthCare
- And Others.
Download the Digital Twins in Healthcare market report for in-depth insights on segment analysis and forecast
Digital Twins in Healthcare Market Segment Analysis
The patient digital twin category is estimated to account for the largest market share in 2024, supported by the growing prevalence of chronic conditions. NHS England (2022) reported approximately 920,000 individuals in the UK living with heart failure, with 200,000 new cases annually, while the Heart Foundation (2024) reported over 144,000 Australians affected by heart failure. A key example of the technology is the Digital Twin of the Heart, developed by Siemens Healthineers AG, a personalized computational model capable of simulating health scenarios, diagnostic steps, and therapeutic interventions.
Patient digital twins enable tailored treatments based on an individual’s biological makeup, lifestyle, and medical history, simulating responses to medications in advance to reduce trial-and-error prescribing. They also support proactive healthcare by allowing clinicians to detect health risks and monitor disease progression before symptoms appear, predicting flare-ups in conditions such as asthma and diabetes. In surgical applications, these digital twins support personalized pre-operative planning and real-time risk assessments. In April 2025, Unlearn partnered with Trace Neuroscience to optimize ALS clinical trials using Unlearn’s Digital Twin Generator for ALS (ALS DTG) to support Trace Neuroscience’s upcoming Phase 1/2 ALS trial.
North America Digital Twins in Healthcare Market Outlook
North America is projected to hold the largest share of the digital twins in healthcare market in 2024, driven by the rising prevalence of chronic diseases, a growing number of surgical procedures, and supportive regulatory policies from government agencies, along with increased partnerships between healthcare and technology companies.
- GLOBOCAN (2024) reported cancer cases in the U.S. reached 2.38 million in 2022, projected to rise to 2.79 million by 2030; the American Cancer Society (2025) estimated 2.04 million new cancer cases in 2025
- The CDC (2024) reported around 6.2 million U.S. adults had heart failure in 2022, and 20.5 million were living with coronary heart disease
- The CDC (2023) reported approximately 6.7 million individuals aged 65 and older living with Alzheimer’s disease in the U.S., projected to reach 13.9 million by 2060
- The Government of Saskatchewan (2024) reported 6,000 surgeries performed in Canada during the 2023–2024 fiscal year
- The National Institutes of Health (2025) reported the FDA cleared 69 medical devices in 2024 that were developed using digital twin technology
Ongoing innovation continues to accelerate regional growth, including Ontrak Inc.’s May 2024 launch of its Mental Health Digital Twin (MHDT), which combines data-driven insights with human empathy for personalized mental health care.
Recent Developmental Activities in the Digital Twins in Healthcare Market
- In January 2025, Quibim announced USD 50 million in Series A financing, led by Asabys and Buenavista, to advance precision medicine using AI-powered imaging biomarkers, with organ- and lesion-level digital twin solutions including QP-Brain, QP-Prostate, and QP-Liver
Connect with DelveInsight’s Experts for a Detailed Analysis of the Digital Twins in Healthcare Market
Conclusion
The digital twins in healthcare market is poised for robust growth through 2032, supported by the rising global burden of chronic diseases, increasing surgical volumes, and rapid advancements in AI, IoT, and big data analytics. Patient digital twins are expected to remain the dominant segment, driven by their expanding role in personalized treatment planning, predictive risk assessment, and pre-surgical simulation. While high implementation costs and data privacy concerns persist as constraints, continued innovation from key players and expanding applications across drug discovery, clinical trials, and hospital operations are expected to shape the next phase of market transformation, creating substantial opportunities for stakeholders across the healthcare ecosystem.
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharmaceutical companies by providing comprehensive end-to-end solutions to improve their performance. It also offers healthcare consulting services that leverage market analysis to accelerate business growth and overcome challenges with practical approaches.
Media contact
Name: Abhishek kumar
E-mail: info@delveinsight.com
